ECP
VVUS

Empyrean Capital Partners’s Vivus Inc VVUS Stock Holding History

Empyrean Capital Partners’s Portfolio VVUS Stock Details VVUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-200,000
Closed -$4.72M – 73
2015
Q2 		$4.72M Hold
200,000
– – 0.22% 45
2015
Q1 		$4.92M Buy
+200,000
New +$5.56M 0.24% 46

Other funds holding VVUS

NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Empyrean Capital Partners's VVUS Position: Q3 2015 in Review

Empyrean Capital Partners sold out of Vivus Inc (VVUS) in Q3 2015, closing a stake of 200,000 shares — an estimated $4.72M sold.

Empyrean Capital Partners first reported a position in VVUS in Q1 2015 and held it in 2 quarters. The position peaked at $4.92M in Q1 2015. 90 funds tracked by Wall St. Rank hold VVUS as of Q3 2015.

  • Empyrean Capital Partners reported no remaining Vivus Inc position as of Q3 2015 after selling out during the quarter.
  • Empyrean Capital Partners sold 200,000 Vivus Inc shares in Q3 2015, an estimated $4.72M.
  • Empyrean Capital Partners first reported a position in Vivus Inc in Q1 2015 and held it in 2 quarters.
  • Empyrean Capital Partners's Vivus Inc position peaked at $4.92M in Q1 2015.
  • 90 funds tracked by Wall St. Rank held Vivus Inc as of Q3 2015.

Based on Empyrean Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.